{"entity":{"id":"noronha-vanita","kind":"person","name":"Vanita Noronha","aka":[],"tldr":"A medical oncologist who co-leads Tata Memorial's lung cancer trials and built India's geriatric oncology programme.","summary":"Vanita Noronha is Professor of Medical Oncology at Tata Memorial Hospital, part of the Tata Memorial Centre in Mumbai, working in geriatric oncology and lung cancer. She co-leads the hospital's lung cancer trials and co-led the trial of gefitinib with or without pemetrexed and carboplatin chemotherapy in EGFR-mutant lung cancer. She also built India's geriatric oncology programme, establishing a geriatric oncology clinic and research programme based on geriatric assessment. Her interests are lung cancer, geriatric oncology, head and neck cancer and clinical trials.","asOf":"2026-09-08","links":[{"label":"Tata Memorial Centre","url":"https://tmc.gov.in"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Noronha%20V%5BAuthor%5D%20Tata%20Memorial%20lung"}],"tags":[],"related":[],"cancers":["nsclc","head-and-neck"],"sections":[],"technologies":["geriatric-assessment"],"targets":[],"drugs":[],"companies":[],"institutions":["tata-memorial"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Professor of Medical Oncology, Tata Memorial Hospital; geriatric oncology and lung cancer","institutionId":"tata-memorial","specialisms":["Lung cancer","Geriatric oncology","Head and neck cancer","Clinical trials"],"profiles":[{"label":"Tata Memorial Centre","url":"https://tmc.gov.in"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Noronha%20V%5BAuthor%5D%20Tata%20Memorial%20lung"}],"papers":[{"title":"Gefitinib versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-mutated lung cancer","journal":"Journal of Clinical Oncology","year":2020,"doi":"10.1200/JCO.19.01154"},{"title":"Low-dose immunotherapy in head and neck cancer: a randomised study (Tata Memorial)","journal":"Journal of Clinical Oncology","year":2023,"url":"https://doi.org/10.1200/JCO.22.01015","doi":"10.1200/JCO.22.01015"}]},"route":"/people/noronha-vanita/","neighbours":{"cancer":[{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"technology":[{"id":"geriatric-assessment","kind":"technology","name":"Geriatric assessment","route":"/technologies/geriatric-assessment/"}],"institution":[{"id":"tata-memorial","kind":"institution","name":"Tata Memorial Centre","route":"/institutions/tata-memorial/"}],"trial":[{"id":"gefitinib-chemo-tmh","kind":"trial","name":"Gefitinib vs gefitinib plus pemetrexed-carboplatin in EGFR-mutant lung cancer (Tata Memorial)","route":"/trials/gefitinib-chemo-tmh/"},{"id":"low-dose-nivolumab-tmh","kind":"trial","name":"Low-dose nivolumab plus metronomic chemotherapy (Tata Memorial)","route":"/trials/low-dose-nivolumab-tmh/"},{"id":"metronomic-vs-cisplatin-tmh","kind":"trial","name":"Oral metronomic chemotherapy vs intravenous cisplatin (Tata Memorial)","route":"/trials/metronomic-vs-cisplatin-tmh/"}],"paper":[{"id":"paper-patil-low-dose-nivolumab-jco-2023","kind":"paper","name":"Low-dose immunotherapy in head and neck cancer: a randomised study (Tata Memorial)","route":"/key-papers/paper-patil-low-dose-nivolumab-jco-2023/"}]}}